Purpose: To compare the more complex technique, functional principal component analysis (FPCA), to simpler methods of estimating values of sparse and irregularly spaced continuous variables at given time points in longitudinal data using a diabetic patient cohort from UK primary care.
| INTRODUCTION
Opportunities for research using routinely collected data will increase significantly over coming years with expansion of electronic health records (EHR), and investment in e-infrastructure for research, distributed data networks, and patient-centred research. [1] [2] [3] Analysis of data collected primarily for healthcare delivery rather than research generates methodological challenges. Progress is happening in many areas, for example, studying the same question across different geographical settings 4 with different healthcare systems and adjusting for confounders defined and measured differently in different settings. 3 Less attention has been paid to the challenge of dealing with data collected each sequential measurement, 6 averaging measures over yearly intervals 7 or estimating simple linear regression (SLR) lines using 2 or more measurements. More complex techniques are also available, for instance, random effects (RE) modelling, which allows for population and individual varia- 
KEY POINTS
• Measuring outcomes in observational studies at prespecified time intervals is difficult when data are sparse and irregularly spaced.
• Traditional methods of estimation include techniques, such as last-observation-carried-forward linear interpolation, which allow crude estimation of change in continuous variables at specified time points (eg, change at 1 year).
• More complex techniques exist, such as FPCA, to model sparse longitudinal data.
• In patients with diabetes, this study demonstrates that in the setting of sparse and irregularly spaced data, using the more complex method, FPCA, has a marginal benefit. randomly selected patients (Figure 2a ). The temporarily excluded data point was later reinserted and used to calculate (1) prediction error defined as the absolute difference between the actual HbA1c measurement and its estimated value (d) and (2) squared prediction error. This was developed to allow estimation of prediction error at times when outcomes for some patients may not have been measured and could not contribute to the estimation. The procedure of removing a random 25% of final data points was done 6 times to reflect the variability that would occur depending on which data points were sampled. Results across the 6 data sets were pooled with mean and SD values for each measure of predictive accuracy calculated. Coefficients of variation (CV), defined as the ratio of SD to the mean, were also generated as a measure of precision between the 6 replicated data sets.
Linear interpolation methods were used in the primary analysis when estimating the final observation for each individual, as described by Genolini, 14 and summarised in Table 1 .
As an alternative to linear interpolation methods, the arithmetic mean (AM) method was used, which involved simply calculating the aver- One other estimation approach of temporarily excluded values was the use of RE modelling using random intercepts and constant slope. Individuals once again were not assumed to be measured at the same number of time points, but rather at different time points.
This model estimates the individual's values across time on the basis of whatever data that individual has, enhanced by the time trend that is estimated for the sample as a whole but with the added bonus of taking into account the effects of covariates, age and gender, in the model.
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A final approach was to use FPCA methodology in developing patient-specific estimated trajectories, using all data from the whole population, which would then allow estimation of a continuous variable, such as HbA1c, for each individual, not only at the last data point but also at any time point of interest throughout the study period ( Figure 3g ). It is the only method tested that allows for the possibility that HbA1c changes nonlinearly with time, or that patterns of change differ between individuals.
All interpolation methods, including AM and SLR, estimated temporarily excluded values using just that individual's set of data, whereas with the model-based approaches of RE and FPCA, it was necessary to use data available on all subjects in the study cohort when making estimations at specific time points for particular individuals.
A secondary analysis sought to examine whether prediction errors improved for any estimation method by removing the middle data point for the same 6 sets of 1-in-4 randomly selected patients (Figure 2b ).
This analysis allows us to use the additional linear interpolation method, next occurrence carried backward (NOCB) ( Table 1 and Figure 3h ).
Global and local interpolation methods are slightly modified in this analysis as shown in Table 1 and Figures 3i and 3j.
Predictive accuracy of each method was assessed using mean absolute prediction error (MAPE), defined as the average absolute prediction error across the quarter of patients where either their last data points in the primary analysis or their middle data points in the secondary analysis were omitted from the estimation. The distribution of squared prediction errors was examined and mean squared absolute prediction error (MSAPE) was used in method comparisons.
To appreciate the importance of the difference between estimated and true HbA1c, we calculated the proportion of individual absolute prediction errors that were (i) below measurement error and (ii) below a clinically meaningful difference. HbA1c measurement error is considered to be around 0.4% assuming an average HbA1c value of 8%. 16 We defined the clinically meaningful difference as the change in HbA1c associated with a 10% increased risk of any endpoint related to diabetes, which equates to a change in HbA1c of 0.5%.
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The lowest values for MAPE and MSAPE and the highest proportion of absolute prediction errors (i) within a clinically meaningful difference and (ii) within measurement error, indicated the optimal estimation method.
| Factors influencing prediction error
We anticipated that prediction error would be affected by many factors, such as medication, gender, age, switching medication, distance These sensitivity analyses were done only for a single replicated data set. With each stratum, we created a homogeneous population and as such we expected modelling methods to perform better than other approaches that do not take into account population behaviour.
The exception to this is likely to be stratum G, where we restricted the population to patients with highly variable HbA1c and as such the expectation was that all approaches may underperform.
The analysis was conducted using Stata V.12.1 (http://www.stata. com) and R V.3.1.3 (http://www.R-project.org). just 6 replicated data sets, any differences in performance are real and not merely due to random variation.
The best performance was achieved by FPCA where a mean of 54% of subjects had prediction errors less than measurement error compared to a mean of 29% with bisector linear interpolation, the least performing method. FPCA was only marginally better than last-occurrence-carried-forward (LOCF), RE, and AM approaches (Table 2) .
Limiting prediction error assessment to strata A-F, based on a single data set having removed 1-in-4 final data points, produced results that can be seen in Figures S1a -S1d. The overall performance of approaches did not change in pattern from that seen in the whole new user cohort, in that LOCF, AM, RE, and FPCA approaches were optimal followed by SLR, with the remaining linear interpolation methods performing worst. Similar results for stratum G (Figures S2a -S2d) found the pattern of prediction errors within subgroups remained the same, with LOCF, AM, RE, and FPCA generating more accurate predictions. See Table S1 for a summarised version of these results. Table 3 displays results following removal of the middle data point, where the best performance was achieved once again by FPCA, although closely followed by SLR, AM, and RE, whereas low CVs reflect the fact that these differences in performance are not due to random variation. 
| DISCUSSION
This study compared methods for estimating values of a continuous variable, HbA1c, at a given time point using known values of this sparse and irregularly spaced data point within UK primary care records of patients with diabetes. Few studies exist, which investigate the effectiveness of these methods, yet researchers apply them without considering their performance.
In Table 2 , when estimating the last observation in the primary analysis, LOCF and FPCA proved to be optimal approaches, with FPCA performing marginally better in some assessments, whereas the remaining linear interpolation methods were equally poor. As the populations were made more homogeneous, such as restricting to females or by having single continuous drug use, the more complex modelling involved in RE and FPCA approaches did not outperform the simpler LOCF method, although FPCA achieved slightly better results overall. For example, under FPCA, 59% of female subjects achieved prediction errors below measurement error compared with 54% under LOCF, whereas the least performing method, bisector linear interpolation, only achieved 32%. We expected an optimal performance from FPCA because of its flexibility to deal with longitudinally nonlinear changes in HbA1c, yet the advantage in using this approach and AM all assume the outcome does not change with time, whereas RE and SLR both assume it changes linearly, and FPCA allows for nonlinear changes. When deciding therefore which estimation method is most appropriate, consideration should be given to whether the data violate any underlying assumptions. Fifth, these methods do not account for uncertainty associated with missing values and so using them will produce estimates that are too precise and will lead to potential bias in subsequent analyses. Finally, underrepeated sampling, using the whole cohort only, was justified since the vast majority of CVs were below 3%. However, it is an assumption that as a consequence there would be no change in the order of each method's performance for strata A-G.
In summary, we have shown that there is a marginal benefit to using the more complex FPCA model when estimating missing HbA1c values in a cohort of patients with diabetes, as results for this model are generally better than all other approaches. However, FPCA is a significantly more complex technique to implement, although worth considering due to the problems attached to using more simple approaches. Caution is needed in extrapolating these findings to other settings as the most appropriate method when estimating values at
given time points will likely depend on the variable of interest, the population in which it is measured, where the missing data actually exist, how homogeneous the population is to start with, and the behaviour of patients and clinicians. 
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